Clinical Trial Update: Nemtabrutinib With Rituximab for the Treatment of Patients With Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nemtabrutinib in combination with rituximab for mantle cell lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Nemtabrutinib (nemtabrutinib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: RECRUITING